Curapath Appoints Philippe Clavel as Chief Executive Officer
December 15, 2023
Curapath, a developer, manufacturer, and formulator of lipid- and polymer-based nanoparticles used in advanced therapeutic delivery technology, today announced the appointment of Philippe Clavel as Chief Executive Officer. Curapath is a portfolio company of Arcline Investment Management. Philippe has previously held leadership positions in the pharmaceutical and biotechnology industries. Most recently, he
